Longevity Startup Brings Anti-Aging Gene Therapy to Human Trials
Life Biosciences, a Boston-based biotech company founded by Harvard professor David Sinclair, is testing cellular reprogramming to turn back the clock on aging.
The company is developing a treatment that could address age-related diseases like Alzheimer’s, Type 2 diabetes, and Parkinson’s.
This potential breakthrough for longevity science also raises ethical concerns, from overpopulation to “hyper-beautification.”
Author's summary: Life Biosciences tests anti-aging gene therapy.
More News
- An Illinois wealth tax would be a legal disaster
- New landowner guides to energy development | Pembina Institute
- Ugly estate disputes are getting more common, but can be prevented
- Inquiring Photographer: Thoughts on Reduced Speed Limit for E-bikes and E-Scooters of 15 mph - Norwood News
- Editorial: Movable bike barrier a good step for Richmond Bridge
- Tomago’s slow death exposes folly of ‘Made in Australia’ dream